spacer

CDC HomeHIV/AIDS > Topics > Research > Prevention Research Synthesis > 2008 Compendium of Evidence-Based HIV Prevention Interventions

spacer spacer
spacer
Skip Nav spacer
Other Interventions from the Original Compendium
spacer
spacer

The original PRS efficacy review, including studies published between 1988 and 1996, identified 24 evidence-based behavioral interventions. These interventions were summarized in the Compendium of HIV Prevention Interventions with Evidence of Effectiveness (CDC, 1999) [1].  Refer to Review findings for more details about the original and updated findings. This original review was based on the Compendium criteria. Since then PRS strengthened its criteria for identifying evidence-based, individual- and group-level behavioral interventions. More details about these criteria can be found at Efficacy criteria

Half of the 24 HIV behavioral interventions that were identified in the original Compendium of HIV Prevention Interventions with Evidence of Effectiveness using the less rigorous Compendium criteria meet either the current best-evidence criteria or the current promising-evidence criteria. There are 12 of the original 24 Compendium interventions that either (1) do not meet the best-evidence and promising-evidence criteria; or (2) have not been evaluated because they are community-level interventions. Eight Compendium interventions are individual- (ILIs) or group-level (GLIs) interventions that do not meet the current criteria for best- or promising-evidence and are listed below, most commonly due to low retention rates or small analytical sample sizes. Most of these ILIs/GLIs fit in Tier III of the Tiers of Evidence Framework.

Four Compendium interventions listed below are community-level interventions (CLIs), which have not yet been evaluated. Because most CLIs have study and design characteristics that do not lend themselves to evaluation with the ILIs and GLIs efficacy criteria, PRS, in consultation with expert methodologists and interventionists, is developing new efficacy criteria for community-level interventions. CDC expects that the review of CLIs will be completed by Spring, 2008.

CDC-funded programs using DEBIsLink to a Non-CDC Web Site that are among the 4 CLIs not yet reviewed or among the 8 ILIs/GLIs not meeting the best-evidence or promising-evidence criteria, can continue implementing these interventions for the time being. Agencies that are planning to implement a new ILI or GLI are encouraged to select an intervention from among the best-evidence or promising-evidence ILI and GLI interventions.

KEY: HS=Heterosexual; HIV+=HIV-positive; HR=High-risk; MSM=Men who have sex with men; DU=Drug users; M=Males; F=Females; W=White; AA=African American; AI=American Indian; H=Hispanic; API=Asian/Pacific Islander; O=Other racial/ethnic group; GLI=group-level intervention; ILI=individual-level intervention

Individual-level and group-level interventions meeting previous Compendium criteria: 

  • SISTA
    Risk category: HS Adult
    Sex: 100% F
    Race: 100% AA
    Delivery Unit: GLI
  • Skill Building
    Risk category: DU
    Sex: 100% F
    Race: 64% H, 36% AA
    Delivery Unit: GLI

Community-Level Interventions:

  • Community PROMISE
    Risk category: DU, HR Youth, HS Adult, MSM
    Sex: 45% M, 55% F
    Race: 54% AA, 22% W, 19% H, 5% O
    Delivery Unit: CLI, ILI
  • Mpowerment
    Risk category: MSM
    Sex: 100% M
    Race: 81% W, 7% API, 6% H, 4% AA, 2% O
    Delivery Unit: CLI, GLI, ILI
  • POL
    Risk category: MSM
    Sex: 100% M
    Race: 86% W, 14% AA or H
    Delivery Unit: CLI, GLI, ILI
  • RAPP
    Risk category: HS Adult
    Sex: 100% F
    Race: 73% AA, 27% O
    Delivery Unit: CLI, GLI, ILI

Go to top

Last Modified: November 30, 2007
Last Reviewed: November 30, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services